Apomorphine - Harvard Scientific
Alternative Names: Apomorphine hydrochloride - Harvard ScientificLatest Information Update: 24 Sep 2021
At a glance
- Originator BioSphere Technologies
- Developer BioSphere Technologies; Harvard Scientific Corporation
- Class Analgesics; Antiparkinsonians; Aporphines; Erectile dysfunction therapies; Quinolines; Small molecules
- Mechanism of Action Dopamine D2 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Female sexual dysfunction; Male sexual dysfunction
Most Recent Events
- 09 Jan 2004 No development reported - Preclinical for Male sexual dysfunction in USA (PO)
- 25 May 2001 Profile reviewed but no significant changes made
- 25 May 2001 No-Development-Reported for Female sexual dysfunction in USA (PO)